29.03.2024 21:30:00
|
Information on the total number of voting rights and shares
REGULATED INFORMATION
Information on the total number of voting rights and shares
Mont-Saint-Guibert (Belgium), March 29, 2024, 9:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.
- Share capital: EUR 4,927,355.12
- Total number of securities carrying voting rights: 28,682,635 (all ordinary shares)
- Total number of voting rights (= denominator): 28,682,635 (all relating to ordinary shares)
- Number of rights to subscribe to securities carrying voting rights not yet issued:
- 100 "2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);
- 400,500 "2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 400,500 securities carrying voting rights (all ordinary shares); and
- 1,085,500 "2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,085,500 securities carrying voting rights (all ordinary shares); and
- 700,000 "2022 ESOP Warrants” issued on December 28, 2022, entitling their holders to subscribe to a total number of 700,000 securities carrying voting rights (all ordinary shares).
*
* *
Contacts:
Nyxoah
David DeMartino, Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313
Attachment
![](https://ml-eu.globenewswire.com/media/ZWNmZWU4NmEtNjgyZC00N2QyLWIyNzctMWViNjEzODM3ODkxLTEyMDkxODA=/tiny/Nyxoah.png)
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Nyxoah S.A. Registered Shsmehr Nachrichten
13.12.24 |
EQS-News: Nyxoah gibt die Markteinführung der innovativen Genio®-Therapie in England bekannt (EQS Group) | |
13.12.24 |
EQS-News: Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England (EQS Group) | |
06.11.24 |
EQS-News: Nyxoah gibt Finanzergebnisse für das dritte Quartal 2024 bekannt und informiert über die Unternehmensentwicklung (EQS Group) | |
06.11.24 |
EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results (EQS Group) | |
05.11.24 |
EQS-News: Nyxoah kündigt Teilnahme an der Münchner Kapitalmarkt Konferenz und dem Deutschen Eigenkapitalforum an (EQS Group) | |
05.11.24 |
Ausblick: Nyxoah mit Zahlen zum abgelaufenen Quartal (finanzen.net) | |
21.10.24 |
Erste Schätzungen: Nyxoah öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
08.10.24 |
EQS-News: Nyxoah Raises $27 Million through its At-the-Market Offering (EQS Group) |
Analysen zu Nyxoah S.A. Registered Shsmehr Analysen
Aktien in diesem Artikel
Nyxoah S.A. Registered Shs | 11,25 | 4,65% |
|